Lord O'Shaughnessy Alert Sample


Alert Sample

View the Parallel Parliament page for Lord O'Shaughnessy

Information between 2nd December 2021 - 30th May 2024

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Division Votes
8 Dec 2021 - Armed Forces Bill - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and against the House
One of 168 Conservative No votes vs 1 Conservative Aye votes
Tally: Ayes - 215 Noes - 173
13 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and in line with the House
One of 155 Conservative No votes vs 0 Conservative Aye votes
Tally: Ayes - 83 Noes - 183
8 Dec 2021 - Armed Forces Bill - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and against the House
One of 170 Conservative No votes vs 1 Conservative Aye votes
Tally: Ayes - 205 Noes - 183
13 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and in line with the House
One of 150 Conservative No votes vs 1 Conservative Aye votes
Tally: Ayes - 171 Noes - 171
13 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and in line with the House
One of 143 Conservative No votes vs 0 Conservative Aye votes
Tally: Ayes - 71 Noes - 167
14 Dec 2021 - Advanced Research and Invention Agency Bill - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and against the House
One of 144 Conservative No votes vs 0 Conservative Aye votes
Tally: Ayes - 166 Noes - 153
15 Dec 2021 - Health Protection (Coronavirus, Restrictions) (Entry to Venues and Events) (England) Regulations 2021 - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and in line with the House
One of 105 Conservative No votes vs 11 Conservative Aye votes
Tally: Ayes - 38 Noes - 205
15 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and in line with the House
One of 143 Conservative No votes vs 0 Conservative Aye votes
Tally: Ayes - 154 Noes - 165
15 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context
Lord O'Shaughnessy voted No - in line with the party majority and in line with the House
One of 135 Conservative No votes vs 1 Conservative Aye votes
Tally: Ayes - 149 Noes - 149


Tweets
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
28 Nov 2021, 1:40 p.m.

@jonathansimons I think this is 100% right, and indeed the lineage is even longer - going back to Callaghan’s ‘secret garden’ speech in 1976.

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
8 May 2020, 8:08 a.m.

The COVID crisis has brought out the best of Britain’s spirit. Now @ukonward is calling for a #socialstimulus to amplify that spirit so we emerge a stronger, more connected society. ? https://t.co/QQzgqVluo9

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
15 May 2020, 4:31 p.m.

Fantastic report on a cause very close to my heart. Sports clubs like @AFCWimbledon are often the centrepiece of community life - we need to support them during the crisis, and help them lead our recovery. https://t.co/C9gSi0kdxm

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
25 Jun 2020, 10:45 a.m.

@danny__kruger @dianabarran Congratulations Danny - the social fabric project @ukonward is at your service

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
25 Jun 2020, 10:47 a.m.

@virginmedia my internet in London W3 has been down for hours. Your service status webpage is broken. The helpline won’t even accept my call. Awful customer service. When will it be fixed?

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
25 Jun 2020, 11:14 a.m.

@ruskin147 @virginmedia Not working for me in W3. But what’s really bad is service status webpage is broken, the service status info line says no outages, and the helpline is impossible to reach. Terrible service!

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
9 Sep 2020, 10:07 a.m.

Next Monday I'll be launching @ukonward's new report - The State of our Social Fabric - with Culture Secretary @OliverDowden. Sign up to our webinar here (https://t.co/F8VHb0f17E) and join us to discuss this landmark new research on renewing Britain's communities. https://t.co/nBmblKAA9m

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
22 May 2020, 7:15 a.m.

“We could be individualistic, anti-authority, daring and self-sufficient because on an elemental level we felt so damn safe.” Perfect summary of why the covid crisis is accelerating the shift towards security and a #politicsofbelonging https://t.co/5rgawiT1N1

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
12 Apr 2020, 9:04 p.m.

Within great struggles come moments of light. One of these is the idea of #COVID19 contact tracing - the key tech that will get us back to normality. This website explains how it can work https://t.co/yQAyIcn0D2 in a way that fully respects individual privacy. #NHSx

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
1 May 2020, 5:26 p.m.

Very much this ?. And a big shout out to the officials, medical staff, logistics folks and others who helped make it happen. ?? Onwards and upwards https://t.co/l4TGdsVdWK

Link to Original Tweet
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
2 Feb 2021, 2:46 p.m.

As countries map out their COVID recovery, vaccine & immunity passports are a hot topic. The @AdaLovelaceInst has launched a call for evidence https://t.co/zzn8RnRcJz.

Link to Original Tweet



Lord O'Shaughnessy mentioned

Select Committee Documents
Thursday 14th March 2024
Government Response - Government's response to the Science, Innovation and Technology Committee's report 'The antimicrobial potential of bacteriophages'

Science, Innovation and Technology Committee

Found: The Lord O'Shaughnessy review into commercial clinical trials in the UK ( 8) was commissioned by the

Wednesday 6th March 2024
Government Response - Government Response to the Committee's First Report - The antimicrobial potential of bacteriophages

Science, Innovation and Technology Committee

Found: The Lord O'Shaughnessy review into commercial clinical trials in the UK ( 8) was commissioned by the

Tuesday 13th June 2023
Oral Evidence - Lord O'Shaughnessy

Science and Technology Committee (Lords)

Found: Lord O'Shaughnessy Oral Evidence

Tuesday 29th June 2021
Oral Evidence - Sir Patrick Vallance, Government Chief Scientific Adviser, Professor Gideon Henderson (Chief Scientific Advisor at Department of Environment, Food and Rural Affairs), and Professor Charlotte Watts (Chief Scientific Adviser at Foreign, Commonwealth and Development Office)
Sir Patrick Vallance, Government Chief Scientific Adviser, Department of Environment, Food and Rural Affairs, and Foreign, Commonwealth and Development Office

Risk Assessment and Risk Planning - Risk Assessment and Risk Planning Committee

Found: Lord O'Shaughnessy: You will be pleased to know that we are having a round table with the Royal Academy

Monday 12th April 2021
Oral Evidence - Kate Nicholls (CEO at UKHospitality), Eoin Murray (Head of Investment at Hermes Investment), Leigh Pomlett (President at Logistics UK), Joanne Holden (Chief Investment Officer UK at Mercer), and Dr Adam Marshall (Director General at British Chambers of Commerce)
UKHospitality, Hermes Investment, Logistics UK, Mercer, and British Chambers of Commerce

Risk Assessment and Risk Planning - Risk Assessment and Risk Planning Committee

Found: Lord O'Shaughnessy: Yes, indeed, in preparation rather than in response.Leigh Pomlett: Yes, please, or

Thursday 4th March 2021
Oral Evidence - Bruce Carnegie-Brown (Chairman at Lloyd's of London), CEO Julian Enoizi (Chief Executive at Pool Re), Professor Paula Jarzabkowski (Professor of Strategic Management at City's Business School, City, University of London), Huw Evans (Director General at Association of British Insurers), and John Scott (Head of Sustainability Risk at Zurich Insurance Group)
Lloyd's of London, Pool Re, City's Business School, City, University of London, Association of British Insurers, and Zurich Insurance Group

Risk Assessment and Risk Planning - Risk Assessment and Risk Planning Committee

Found: Lord O'Shaughnessy: It would be good to get your thoughts on whether there are other risks that we are

Tuesday 26th January 2021
Oral Evidence - Catherine Wright (Interim Executive Director of Flood and Coastal Risk Management at Environment Agency), Laura Hughes (General Insurance Policy Manager, and flood policy lead at Association of British Insurers), Professor David Balmforth (Past President at Institution of Civil Engineers), and Andy Bord (Chief Executive at Flood Re)
Environment Agency, Association of British Insurers, Institution of Civil Engineers, and Flood Re

Risk Assessment and Risk Planning - Risk Assessment and Risk Planning Committee

Found: Lord O'Shaughnessy: Thank you.

Monday 30th November 2020
Oral Evidence - Roger Hargreaves (Director at Civil Contingencies Secretariat)
Civil Contingencies Secretariat

Risk Assessment and Risk Planning - Risk Assessment and Risk Planning Committee

Found: Lord O'Shaughnessy: If it is not your secretariat™s responsibility, ought there to be someone somewhere



Written Answers
Clinical Trials: Contracts
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central)
Tuesday 30th April 2024

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled Full government response to the Lord O'Shaughnessy review into commercial clinical trials, last updated on 8 December 2023, what her Department's planned timetable is for expanding the national contract value review programme to phase 1 and 2a clinical trials.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The National Contract Value Review (NCVR) process applies to commercial clinical studies. NHS England is working in partnership with the devolved administrations, the National Institute for Health and Care Research, and other partners, to pilot the use of the NCVR process for phase I and IIa of commercial clinical trials. The ambition is to make the use of NCVR for phase I and IIa of commercial clinical trials mainstream from October 2024.

Commercial Clinical Trials in the UK Review
Asked by: Ranil Jayawardena (Conservative - North East Hampshire)
Tuesday 21st November 2023

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department has taken to implement the (a) significant actions under problem statement 6 and (b) other recommendations of the Lord O'Shaughnessy review of commercial clinical trials.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Government will soon publish a full response to the Lord O’Shaughnessy independent review into commercial clinical trials.

The response will include an update on progress and implementation of the initial five headline commitments and foundational actions that the Government made in May 2023 as well as all other recommendations in the review.

IVF
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Tuesday 13th June 2023

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 6 April 2017 (HL6515), whether the Human Fertilisation and Embryology Authority has been made aware that any child born as a result of mitochondrial donation has (1) a mitochondrial disease, (2) birth defect, (3) genetic abnormality, or (4) any other adverse outcome.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Human Fertilisation and Embryology Authority has advised that it cannot provide the detailed information as requested as it may compromise patient confidentiality.

Clinical Trials: Reviews
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central)
Tuesday 28th March 2023

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, with reference to the press release entitled Lord O'Shaughnessy to lead independent review into UK clinical trials, published on 20 February 2023, how many staff from the Department of (a) Science, Innovation and Technology, (b) Health and Social Care and (c) Business and Trade will be involved in the review.

Answered by George Freeman

The Office for Life Sciences is providing secretariat support for the review and is a joint unit between Department for Health and Social Care and Department for Science, Innovation and Technology. Three members of OLS staff are involved in this secretariat function as part of their roles. No members of the Department for Business and Trade are providing direct support. Officials from both DHSC and DSIT are providing evidence for the review as experts in Clinical Research.

Clinical Trials: Reviews
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central)
Wednesday 1st March 2023

Question to the Department for Science, Innovation & Technology:

To ask Secretary of State for Science, Innovation and Technology, with reference to the press release entitled Lord O'Shaughnessy to lead independent review into UK clinical trials, published on 20 February 2023, what the salary for leading the review is.

Answered by George Freeman

Lord O’Shaughnessy has been appointed as Chair for the independent review into UK clinical trials. Lord O’Shaughnessy is not a government official and the role is unpaid.

Clinical Trials: Reviews
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central)
Monday 27th February 2023

Question to the Department for Science, Innovation & Technology:

To ask Secretary of State for Science, Innovation and Technology, with reference to the press release entitled Lord O'Shaughnessy to lead independent review into UK clinical trials, published on 20 February 2023, what budget her Department has allocated to the review.

Answered by George Freeman

No specific budget has been allocated to the review. Existing staff have been temporarily re-allocated in order to support the running of the review.

Lord O'Shaughnessy
Asked by: Angela Rayner (Labour - Ashton-under-Lyne)
Monday 25th April 2022

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what records his Department holds of correspondence between Lord O'Shaughnessy and companies providing covid-19 testing or testing supplies, between April and August 2020, conducted on his private gmail account; and whether he was provided with a departmental email address in his capacity as an adviser on NHS Test and Trace during this period.

Answered by Edward Argar - Minister of State (Ministry of Justice)

The Department holds copies of correspondence between Lord O’Shaughnessy’s Gmail account and Government officials, companies and organisations working on COVID-19 testing and testing supplies issues between April and August 2020. During this period Lord O’Shaughnessy was provided with a Departmental email address.

Centre for Improving Data Collaboration
Asked by: Angela Rayner (Labour - Ashton-under-Lyne)
Tuesday 22nd March 2022

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department holds a minute of the meeting between the Parliamentary Under Secretary for Innovation, Lord O'Shaughnessy and Imperial College London regarding the Centre for Improving Data Collaboration; whether Departmental officials were present; and in what capacity Lord O'Shaugnessy attended that meeting.

Answered by Gillian Keegan - Secretary of State for Education

Lord O’Shaughnessy and colleagues at the Imperial Institute for Global Health Innovation undertook a piece of research on behalf of the NHSX Centre for Improving Data Collaboration, to contribute to the development of the Value Sharing Framework for health data partnerships. Departmental officials were present and the Department holds a minute of the meeting.

OC&C Strategy Consultants
Asked by: Rachel Hopkins (Labour - Luton South)
Tuesday 22nd March 2022

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department holds a minute of the meetings between the Parliamentary Under Secretary of State for Innovation, Lord O'Shaughnessy and OC&C strategy consultants on 13 April 2020; who attended the meeting on behalf of OC&C; whether officials or special advisers attended the meeting on behalf of his Department; and in what capacity Lord O'Shaughnessy was attending.

Answered by Edward Argar - Minister of State (Ministry of Justice)

The Department holds notes of the actions arising from this meeting. Lord Bethell was supported by a private secretary, Departmental officials and officials from the Department for International Trade, Department for Environment, Food and Rural Affairs and NHS England. Lord O'Shaughnessy and Bennet Summers, Vivek Madan and Henry Stannard of OC&C Strategy also attended the meeting. Special advisors were not present. Lord O'Shaughnessy attended in an advisory capacity.



Parliamentary Research
Musculoskeletal conditions and employment - CDP-2023-0236
Dec. 20 2023

Found: Answering member: Lord O'Shaughnessy | Department: Department of Health and Social Care The Government

Eye health and macular disease - CDP-2021-0220
Dec. 23 2021

Found: Answering member: Lord O'Shaughnessy | Department of Health Bevacizumab (Avastin) is not licensed



Department Publications - Policy and Engagement
Friday 1st March 2024
Department of Health and Social Care
Source Page: The antimicrobial potential of bacteriophages report: government response
Document: Government's response to the Science, Innovation and Technology Committee's report 'The antimicrobial potential of bacteriophages' (PDF)

Found: The Lord O'Shaughnessy review into commercial clinical trials in the UK ( 8) was commissioned by the

Wednesday 22nd November 2023
Department of Health and Social Care
Source Page: Government response to the review into commercial clinical trials
Document: Government response to the review into commercial clinical trials (webpage)

Found: Government response to the review into commercial clinical trials The full government response to the Lord



Deposited Papers
Tuesday 28th November 2023
Department of Health and Social Care
Source Page: Policy paper. Full government response to the Lord O'Shaughnessy review into commercial clinical trials. 40p.
Document: Full_response-OShaughnessy_Review.pdf (PDF)

Found: Full government response to the Lord O'Shaughnessy review into commercial clinical trials. 40p.




Lord O'Shaughnessy mentioned in Scottish results


Scottish Cross Party Group Publications
Minutes of the meeting held on 30 May 2023 (PDF)
Source Page: Cross-Party Group in the Scottish Parliament on Life Sciences
Published: 30th May 2023

Found: Asked for her views on the recently published Lord O'Shaughnessy report which makes a series of re